This page shows Carter Bankshares Inc (CARE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A larger balance sheet, not heavier reinvestment, drives this business, while a thin equity base sets the real constraint.
Over the last two years, return on assets improved only from0.5% to0.7% . Meanwhile assets reached$4.85B , showing the company added balance-sheet volume faster than it improved profit earned on each dollar deployed.
The business looks cash-generative in a balance-sheet sense: operating cash flow of
Funding remains heavily leveraged: liabilities were
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Carter Bankshares Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Carter Bankshares Inc's revenue grew a modest 4.6% year-over-year to $20.3M. This slow but positive growth earns a score of 47/100.
Carter Bankshares Inc has elevated debt relative to equity (D/E of 10.56), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
Carter Bankshares Inc converts 156.6% of revenue into free cash flow ($31.8M). This strong cash generation earns a score of 100/100.
Carter Bankshares Inc generates a 7.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 27/100. This is up from 6.4% the prior year.
Carter Bankshares Inc passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Carter Bankshares Inc generates $1.27 in operating cash flow ($39.9M OCF vs $31.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Carter Bankshares Inc generated $20.3M in revenue in fiscal year 2025. This represents an increase of 4.6% from the prior year.
Carter Bankshares Inc reported $31.4M in net income in fiscal year 2025. This represents an increase of 27.9% from the prior year.
Carter Bankshares Inc earned $1.38 per diluted share (EPS) in fiscal year 2025. This represents an increase of 30.2% from the prior year.
Cash & Balance Sheet
Carter Bankshares Inc generated $31.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 10.4% from the prior year.
Carter Bankshares Inc held $105.2M in cash against $0 in long-term debt as of fiscal year 2025.
Carter Bankshares Inc had 22M shares outstanding in fiscal year 2025. This represents a decrease of 4.3% from the prior year.
Margins & Returns
Carter Bankshares Inc's net profit margin was 154.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 28.1 percentage points from the prior year.
Carter Bankshares Inc's ROE was 7.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.1 percentage points from the prior year.
Capital Allocation
Carter Bankshares Inc spent $20.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Carter Bankshares Inc invested $8.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 1.0% from the prior year.
CARE Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $59.2M | N/A | $59.2M+2.5% | $57.7M+3.1% | $56.0M | N/A | $56.6M+3.7% | $54.6M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $14.9M | N/A | $14.0M-0.4% | $14.1M+3.1% | $13.7M | N/A | $14.6M+2.7% | $14.2M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $23.3M | N/A | $25.5M+0.2% | $25.4M-1.9% | $25.9M | N/A | $27.8M+4.9% | $26.5M |
| Income Tax | $24.3M | N/A | $1.7M-18.1% | $2.1M-3.0% | $2.2M | N/A | $1.4M+24.8% | $1.1M |
| Net Income | $85.8M | N/A | $5.4M-36.3% | $8.5M-4.9% | $9.0M | N/A | $5.6M+17.2% | $4.8M |
| EPS (Diluted) | $3.88 | N/A | $0.24-35.1% | $0.37-5.1% | $0.39 | N/A | $0.24+14.3% | $0.21 |
CARE Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.8B-1.1% | $4.9B+0.2% | $4.8B+1.2% | $4.8B+1.8% | $4.7B+0.9% | $4.7B+1.0% | $4.6B+1.8% | $4.5B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $228.3M+117.1% | $105.2M-1.7% | $106.9M+7.0% | $99.9M+12.3% | $89.0M-32.2% | $131.2M+24.9% | $105.0M+70.0% | $61.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $1.2M0.0% | $1.2M0.0% | $1.2M0.0% | $1.2M | N/A | $0 | N/A | N/A |
| Total Liabilities | $4.3B-3.1% | $4.4B+0.1% | $4.4B+1.1% | $4.4B+1.9% | $4.3B+0.6% | $4.3B+1.1% | $4.2B+1.4% | $4.2B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $504.9M+20.3% | $419.7M+1.7% | $412.8M+1.8% | $405.6M+1.0% | $401.8M+4.5% | $384.3M-0.6% | $386.8M+6.2% | $364.4M |
| Retained Earnings | $450.7M+23.5% | $365.0M+2.4% | $356.5M+1.5% | $351.1M+2.5% | $342.6M+2.7% | $333.6M+2.5% | $325.3M+1.8% | $319.7M |
CARE Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $303.9M+2417.5% | $12.1M+2.2% | $11.8M+23.1% | $9.6M+50.5% | $6.4M-44.3% | $11.5M+11.0% | $10.3M+519.4% | -$2.5M |
| Capital Expenditures | $1.5M-50.0% | $3.1M+99.9% | $1.5M-19.7% | $1.9M+25.9% | $1.5M-51.5% | $3.1M+66.9% | $1.9M+3.8% | $1.8M |
| Free Cash Flow | $302.4M+3261.2% | $9.0M-12.5% | $10.3M+33.8% | $7.7M+58.3% | $4.9M-41.6% | $8.3M-1.4% | $8.4M+297.5% | -$4.3M |
| Investing Cash Flow | -$26.6M-132.7% | -$11.4M+77.1% | -$50.0M-271.8% | -$13.4M+83.4% | -$81.1M-141.1% | -$33.6M-47.3% | -$22.8M-2.9% | -$22.2M |
| Financing Cash Flow | -$154.1M-6279.9% | -$2.4M-105.3% | $45.2M+206.5% | $14.7M-54.6% | $32.5M-32.8% | $48.4M-13.3% | $55.8M+356.8% | -$21.7M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | $6.0M+21.5% | $4.9M | N/A | N/A | $0 | $0 | $0 |
CARE Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 144.9% | N/A | 9.2%-5.6pp | 14.7%-1.2pp | 16.0% | N/A | 10.0%+1.2pp | 8.8% |
| Return on Equity | 17.0% | N/A | 1.3%-0.8pp | 2.1%-0.1pp | 2.2% | N/A | 1.5%+0.1pp | 1.3% |
| Return on Assets | 1.8% | N/A | 0.1%-0.1pp | 0.2%-0.0pp | 0.2% | N/A | 0.1%0.0pp | 0.1% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 8.51-2.1 | 10.56-0.2 | 10.72-0.1 | 10.79+0.1 | 10.70-0.4 | 11.12+0.2 | 10.93-0.5 | 11.44 |
| FCF Margin | 510.9% | N/A | 17.4%+4.1pp | 13.3%+4.6pp | 8.7% | N/A | 14.9%+22.7pp | -7.8% |